UK markets closed

MyMD Pharmaceuticals, Inc. (0A8D.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
3.2300+0.3100 (+10.62%)
At close: 05:13PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 3.17
52-week change 3-92.09%
S&P500 52-week change 322.38%
52-week high 340.7700
52-week low 32.9279
50-day moving average 35.9266
200-day moving average 313.1314

Share statistics

Avg vol (3-month) 3429
Avg vol (10-day) 31.24k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 81.93M
% held by insiders 17.32%
% held by institutions 19.45%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.033333:1
Last split date 315 Feb 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-57.77%
Return on equity (ttm)-29.12%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-8.22M
Diluted EPS (ttm)-0.2230
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.92M
Total cash per share (mrq)2.28
Total debt (mrq)48.87k
Total debt/equity (mrq)0.38%
Current ratio (mrq)1.17
Book value per share (mrq)6.05

Cash flow statement

Operating cash flow (ttm)-12.98M
Levered free cash flow (ttm)-5.27M